Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Biomedtracker
By Amanda Micklus 19 Jun 2018
Gain a deeper understanding of the implications of the Regenerative Medicine Advanced Therapies (RMAT) designation and the significance of its support and advancement by the FDA in this webinar recording, "RMAT Designation – Impact on Regenerative Medicine Sector".
Awareness
By Dominique Fontanilla 19 Jun 2018
There has been little change to standard treatment for AML in recent years; however, 2017 saw a flurry of new targeted drug approvals, sparking significant market growth. Patient age remains the biggest factor in driving treatment decisions for AML. Cases of AML are expected to increase, and prognosis remains poor – especially among older adults. Drug developers are targeting patient segments with high unmet clinical need to gain access to the AML market and the budget impact of AML is expected to grow considerably.
Topic Cancer
Awareness
By Patricia Reilly 19 Jun 2018
The promises of gene therapy are taking a long time to be fulfilled, in part due to challenges in developing gene vectors capable of safe and efficient delivery of therapeutic genes (transgenes) into patients’ cells. Nonetheless, these challenges are being addressed in innovative ways. A variety of first-generation vectors, both viral and non-viral, have been employed in clinical trials with varying degrees of success, and the experience gained is guiding the design of next-generation vectors.
Meddevicetracker
By Tina Tan 15 Jun 2018
The webinar will provide a thought leadership perspective on the key challenges and trends in the emerging Robotic Surgery market.
Topic Digital Health Research
Medtech Insight
By Reed Miller 14 Jun 2018
Results of the WATER II trial confirm that Aquablation is a safe and effective treatment of benign prostate hyperplasia for large prostates, and manufacturer Procept BioRobotics is confident the procedure will eventually displace all other prostate resection techniques because it is easy for surgeons to learn.
In Vivo
By Ashley Yeo 14 Jun 2018
The health products industry, methods of care delivery and even the public's expectations for improved tools to prevent, monitor and treat disease have transformed dramatically in the past five years. The changes anticipated over a similar period ahead are potentially even more marked, with business continuity impacts for medtech and pharma concerns, according to Deloitte LLP experts who were on the circuit at health care industry events in Germany and the UK this spring.
In Vivo
By Mark Ratner 14 Jun 2018
A plethora of clinical studies are showing that new types of data, often captured in the EHR, can help improve the correlation between treatments and outcomes and favorably affect patient care as well as enhance drug development.
Pink Sheet
By Sue Sutter 14 Jun 2018
Internal group headed by Principal Deputy Commissioner Rachel Sherman will develop implementation recommendations, which could include new guidance, regulations, a Q&A document or ‘nothing at all,’ Commissioner Gottlieb tells BIO annual meeting; he promises consultation with the law’s supporters and critics on Capitol Hill ‘to fully understand what the intent was with different provisions.’
Topic FDA
Pink Sheet
By Emily Hayes 14 Jun 2018
Genentech says it worked closely with the agency to bring the drug to women with earlier-stage disease.
Medtech Insight
By Amanda Maxwell 14 Jun 2018
The new EU Medical Device Regulation offers companies an option to market CE-marked devices for an extra four years under current directives. But more hurdles are being identified that make this option less attractive.
Topic Brexit Business strategies
Scrip
By Brian Yang 14 Jun 2018
Recent biotech investment deals involving WuXi, Oncologie and Siranomics show Chinese investors are becoming increasingly bold and savvy in betting on innovative assets both inside and outside the country.
Topic BioPharmaceutical
Scrip
By Joseph Haas 14 Jun 2018
Having previously criticized the biopharma industry for squandering the benefits of US tax reform, the former Teva CEO called for more M&A deals that offer a clear strategic rationale, pointing to Takeda/Shire as an example.
Topic BioPharmaceutical
Datamonitor Healthcare
By Jack Allen 08 Jun 2018
Zach McLellan and Jack Allen are joined by guest analysts Dominique Fontanilla and Hardik Patel. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.
Topic Cancer
Datamonitor Healthcare
By Jack Allen 08 Jun 2018
Zach McLellan and Jack Allen are joined by guest analyst Maria Berezina. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.
Topic Cancer
Scrip
By Emily Hayes 06 Jun 2018
The cancer immunotherapy combo showed "remarkable" effects in patients who tested negative for PD-L1 expression and would normally not respond well to immunotherapy.
Scrip
19 Jun 2018
Pink Sheet
18 Jun 2018
In Vivo
18 Jun 2018
In Vivo
18 Jun 2018
Medtech Insight
18 Jun 2018
Medtech Insight
18 Jun 2018
Scrip
18 Jun 2018
Pink Sheet
18 Jun 2018
Pink Sheet
18 Jun 2018
Pink Sheet
18 Jun 2018
Pink Sheet
18 Jun 2018
Medtech Insight
18 Jun 2018
Pink Sheet
18 Jun 2018
Scrip
18 Jun 2018
Scrip
18 Jun 2018
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
20 Jun 2018 , 14:00 BST
Japan
Webinar
23 Sep 2018
USA
Awards
09 Oct 2018
Spain
Awards
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date